Evidence map›Paper›PMID 40273414›Full record

ArticlePLoS computational biology2025

Efficient discovery of frequently co-occurring mutations in a sequence database with matrix factorization.

Michael Robert Kolar, Valerie Kobzarenko, Debasis Mitra

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael Robert KolarBiC Lab, Department of Electrical Engineering and Computer Science, Florida Institute of Technology, Melbourne, Florida, United States of America.ORCID 0009-0005-9738-2985
Valerie KobzarenkoBiC Lab, Department of Electrical Engineering and Computer Science, Florida Institute of Technology, Melbourne, Florida, United States of America.
Debasis MitraBiC Lab, Department of Electrical Engineering and Computer Science, Florida Institute of Technology, Melbourne, Florida, United States of America.

Funding

INCREASING CLINICAL ACCESS BY REDUCING SCAN TIME OF DYNAMIC NUCLEAR CARDIAC IMAGING WITH SUPERIOR DIAGNOSISR15EB030807 · NIBIB · FLORIDA INSTITUTE OF TECHNOLOGY · PI MITRA, DEBASIS · 2021 to 2021
$455k
NIBIB NIH HHS R15 EB030807
6 · The paper itself

Abstract

We have developed a robust method for efficiently tracking multiple co-occurring mutations in a sequence database. Evolution often hinges on the interaction of several mutations to produce significant phenotypic changes that lead to the proliferation of a variant. However, identifying numerous simultaneous mutations across a vast database of sequences poses a significant computational challenge. Our approach leverages a matrix factorization technique to automatically and efficiently pinpoint subsets of positions where co-mutations occur, appearing in a substantial number of sequences within the database. We validated our method using SARS-CoV-2 receptor-binding domains, comprising approximately seven hundred thousand sequences of the Spike protein, demonstrating superior performance compared to a reasonably exhaustive brute-force method. Furthermore, we explore the biological significance of the identified co-mutational positions (CMPs) and their potential impact on the virus's evolution and functionality, identifying key mutations in Delta and Omicron variants. This analysis underscores the significant role of identified CMPs in understanding the evolutionary trajectory. By tracking the "birth" and "death" of CMPs, we can elucidate the persistence and impact of specific groups of mutations across different viral strains, providing valuable insights into the virus' adaptability and thus, possibly aiding vaccine design strategies.

Indexed as

MutationSARS-CoV-2AlgorithmsComputational BiologyCOVID-19Databases, GeneticEvolution, MolecularHumansSpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID40273414
PMCPMC12273922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.